(Q34206291)

English

An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Rebecca A Marsh

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Mi-Ok Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Chunyan Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Denise Bellman

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Laura Hart

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Michael Grimley

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ashish Kumar

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sonata Jodele

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Kasiani C Myers

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sharat Chandra

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Tom Leemhuis

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Parinda A Mehta

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jack J Bleesing

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Stella M Davies

14

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Michael B Jordan

15

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Alexandra H Filipovich

16

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

10 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1625-1631

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

The outcome of hematopoietic stem cell transplantation in Korean children with hemophagocytic lymphohistiocytosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

5 July 2018

The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

5 July 2018

Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

5 July 2018

Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

5 July 2018

Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

5 July 2018

Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

5 July 2018

Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

5 July 2018

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

5 July 2018

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

5 July 2018

Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

28 October 2018

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

28 October 2018

Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

28 October 2018

Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

28 October 2018

Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

28 October 2018

A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167781

28 October 2018

Pharmacokinetics of CAMPATH-1H in BMT patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24035782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/24035782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/24035782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24035782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/24035782

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2013.09.001

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34206291&oldid=1542965302"